Showing 1 - 10 of 931
Persistent link: https://www.econbiz.de/10008655517
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...
Persistent link: https://www.econbiz.de/10009691207
Persistent link: https://www.econbiz.de/10009762378
a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub …
Persistent link: https://www.econbiz.de/10008749029
Persistent link: https://www.econbiz.de/10009270541
accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper …
Persistent link: https://www.econbiz.de/10003826591
Persistent link: https://www.econbiz.de/10002236507
accounting for 8% of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper …
Persistent link: https://www.econbiz.de/10013136585
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...
Persistent link: https://www.econbiz.de/10013139185
accounting for 8 per cent of total pharmaceutical sale in Norway. Novelty of the paper is to examine, with the use of a unique … natural policy experiment in Norway, to what extent the price responsiveness of prescription choices is affected when the …
Persistent link: https://www.econbiz.de/10013118139